Petra Stieber

Title: Petra Stieber: Innovator in Apoptotic Product Detection

Introduction

Petra Stieber is a prominent inventor based in Gauting, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the detection of apoptotic products in tumor patients undergoing therapy. With a total of 2 patents, her work has the potential to enhance the effectiveness of cancer treatments.

Latest Patents

Stieber's latest patents focus on innovative methods for determining apoptotic products in patient samples. One of her notable inventions is a method for assessing the concentration of apoptotic products, which correlates with the effectiveness of therapy. This method is particularly useful for evaluating the effectiveness of tumor therapy in patients undergoing radiotherapy or chemotherapy. Additionally, her inventions include techniques for determining the concentration of nucleosomes in serum samples, which serve as a follow-up for therapy effectiveness.

Career Highlights

Petra Stieber is currently employed at Roche Diagnostics GmbH, where she continues to advance her research in medical diagnostics. Her work has been instrumental in developing methods that can significantly impact patient care and treatment outcomes.

Collaborations

Throughout her career, Stieber has collaborated with notable colleagues, including Martin Busch and Andreas Schalhorn. These partnerships have contributed to the success of her innovative projects and the advancement of medical diagnostics.

Conclusion

Petra Stieber's contributions to the field of medical diagnostics through her innovative patents demonstrate her commitment to improving patient outcomes in cancer therapy. Her work continues to pave the way for advancements in the detection of apoptotic products, showcasing the importance of innovation in healthcare.